Use of cardiac radiation therapy as bridging therapy to CAR‐T for relapsed pediatric B‐cell acute lymphoblastic leukemia
Pediatric Blood & Cancer2020Vol. 68(3), pp. e28870–e28870
Citations Over Time
César Márquez, Raúl Montiel-Esparza, Caressa Hui, Liora M. Schultz, Kara L. Davis, Richard T. Hoppe, Sarah S. Donaldson, Sneha Ramakrishna, Susan M. Hiniker
Abstract
The use of radiotherapy as bridging therapy to chimeric antigen receptor T-cell therapy (CAR-T) in pre-B acute lymphoblastic leukemia (B-ALL) has been minimally explored. Here, we present a boy with B-ALL who relapsed after allogeneic bone marrow transplant with disseminated disease, including significant symptomatic cardiovascular and gastrointestinal (GI) involvement. The cardiac and GI leukemic infiltrates were successfully treated with bridging radiation therapy (BRT) prior to CAR-T infusion. Using this approach, he successfully tolerated CAR-T with no evidence of disease or sequelae on 3-month follow-up. This is the first reported case of safe and effective delivery of cardiac BRT in B-ALL.
Related Papers
- → You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy(2020)109 cited
- → Early and Late Toxicities of Chimeric Antigen Receptor T-Cells(2023)10 cited
- → Chimeric antigen receptor-redirected T cells return to the bench(2016)35 cited
- → [Prospect for chimeric antigen receptor-engineered T cell immunotherapy for solid tumors].(2018)
- → [Advances in Structural Designs of Chimeric Antigen Receptor T Cells--Review].(2022)